Biochemical and Pharmacological Characterization of TLBbar, a New Serine Protease with Coagulant Activity from <i>Bothrops barnetti</i> Snake Venom

<table>Coagulant activity of TLBbar. Minimum dose coagulant (MDC) on TLBbar human plasma at various concentrations (1, 3, 5, 10, 15 and 20 <i>μ</i>g).</table>

Journal of Toxins

fig6

Figure 6

Figure 6: Biochemical and Pharmacological Characterization of TLBbar, a New Serine Protease with Coagulant Activity from <i>Bothrops barnetti</i> Snake Venom 

Figure 6 | Biochemical and Pharmacological Characterization of TLBbar, a New Serine Protease with Coagulant Activity from Bothrops barnetti Snake Venom 